VASCULAR PHOTOBIOMODULATION AS A USEFUL TOOL IN HYPOSALIVATION AND XEROSTOMIA OF DIABETES MELLITUS PATIENTS: CASE REPORT

Hyposalivation (HS) and xerostomia (XT) are prevalent oral complications among patients with type 2 diabetes mellitus (T2DM), and vascular photobiomodulation has demonstrated potential in regulating various systems in these individuals. Vascular photobiomodulation is considered a promising tool in o...

Full description

Saved in:

Bibliographic Details
Published in:	Oral surgery, oral medicine, oral pathology and oral radiology Vol. 137; no. 6; p. e232
Main Authors:	FONTES, Karla Bianca Fernandes da Costa, SCHAUS ABREU, Carla Cristine, da ROSA, Maitée Carolinne Castilho
Format:	Journal Article
Language:	English
Published:	Elsevier Inc 01-06-2024
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Hyposalivation (HS) and xerostomia (XT) are prevalent oral complications among patients with type 2 diabetes mellitus (T2DM), and vascular photobiomodulation has demonstrated potential in regulating various systems in these individuals. Vascular photobiomodulation is considered a promising tool in oral medicine due to its scientific basis for modulating a wide range of chemical and enzymatic reactions. In the case of a 53-year-old female patient with T2DM, suffering from HS and XT, a vascular photobiomodulation therapy was administered. This therapy involved continuous and direct transcutaneous application using a red laser source (660nm, Indium Gallium Aluminum Phosphide, 100mW) on the left radial artery, with a total energy dose of 180J over 30 minutes (Therapy EC, DMC, São Paulo, Brazil), administered weekly for 10 weeks. The patient's HS and XT levels were assessed on days 1, 5, and 10 of treatment. Notably, the patient exhibited an increase in both unstimulated and stimulated salivary flow rates, alongside a reduction in xerostomia and pain values following the vascular photobiomodulation therapy. These results suggest that vascular photobiomodulation may offer significant benefits to T2DM patients dealing with hyposalivation and xerostomia.
ISSN:	2212-4403 2212-4411
DOI:	10.1016/j.oooo.2023.12.412